Continuous vs Intermittent β-Lactam Antibiotic Infusions in Patients With Sepsis
12/6/2024
0:00
9:57
Joel M. Dulhunty, MD, PhD, Royal Brisbane and Women’s Hospital, and Jason A. Roberts, BPharm, PhD, University of Queensland Centre for Clinical Research, join JAMA Deputy Editor Preeti Malani, MD, MSJ, to discuss the BLING trial that assessed continuous vs intermittent β-lactam antibiotic infusions in patients with sepsis or septic shock.
Related Content:
Altri episodi di "JAMA Author Interviews"
Non perdere nemmeno un episodio di “JAMA Author Interviews”. Iscriviti all'app gratuita GetPodcast.